2-(5-fluoropentyl)-2-methylmalonic acid
This molecular is a [18F] PET (positron emission tomography) radiotracer. It can accumulate in cells presenting apoptosis-specific membrane alterations. ML-10 allows for the detection of apoptotic cells located in atherosclerotic plaques. In Jun 2015, GlaxoSmithKline terminated a phase II trial in Solid tumours (Diagnosis) in United Kingdom. In Mar 2016, Phase-II for solid tumours, lung cancer and head Brain metastases and neck cancer (Diagnosis) in USA was suspended
| Supplier | BOC Sciences |
|---|---|
| Product # | 1216897-16-3 |
| Pricing | Inquire |
| Cas | 1216897-16-3 |
| Molecular Weight | 206.21 |
| Molecular Formula | C9H15FO4 |
| Canonical SMILES | CC(CCCCCF)(C(=O)O)C(=O)O |